Supportive Care Mobile Application for Patients With NSCLC

Study summary

This research study is looking at the role of a supportive care mobile app in improving symptoms, coping skills, and quality of life in patients with non-small cell lung cancer.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedSupportive Care Mobile Application and Usual Care

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 22, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?6 U.S. locations

Locations may change over time.

Who runs it?Massachusetts General Hospital

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: Massachusetts General Hospital
Interventions being studied: Behavioral: Supportive Care Mobile Application; Other: Usual Care

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type

Non-small cell lung cancer (NSCLC)→

Treatment approach

Supportive or behavioral care→

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Age \>18 years
Diagnosed with unresectable Stage III or IV NSCLC in the past twelve weeks and receiving care with palliative intent (per clinician documentation in the electronic health record)
Eastern Cooperative Oncology Group Performance Status = 0-3
Plan to receive oncology care at one of the participating study sites
Ability to read and respond to questions in English

Reasons someone may not be able to joinExclusion criteria

Significant uncontrolled psychiatric disorder (e.g., psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the ability to participate in study procedures

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Massachusetts General Hospital Cancer CenterBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Mass General/North Shore Cancer CenterDanvers, Massachusetts
Dana-Farber Brigham Cancer Center at Milford Regional Medical CenterMilford, Massachusetts
Newton-Wellesley HospitalNewton, Massachusetts
Dana-Farber Brigham Cancer Center at South ShoreSouth Weymouth, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 22, 2024. Always confirm current availability with the study team.

View original record ↗